Com-Guard.com, Inc. (GUD) – PRNewswire
-
FDA Grants Profounda Orphan Drug Designation Approval for treatment of Treatment of Invasive Candidiasis with Miltefosine
-
Maverix Private Equity Announces Team Additions
-
Knight Partners With Debiopharm for the Commercialization of Trelstar® in Canada
Back to GUD Stock Lookup
